54 results
424B5
URGN
UroGen Pharma Ltd
18 Jun 24
Prospectus supplement for primary offering
5:05pm
;
Persons holding our ordinary shares or pre-funded warrants as part of a hedge, straddle or other risk reduction strategy or as part of a conversion
424B5
URGN
UroGen Pharma Ltd
17 Jun 24
Prospectus supplement for primary offering
4:19pm
strategy or as part of a conversion transaction or other integrated investment for U.S. federal income tax purposes;
banks, insurance companies, and other
8-K
EX-99.1
x2bfqnvd870 ca087m
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
0qfspd6uhn
7 Feb 24
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
zqrz9hwn2o8 w85sl
10 Aug 23
UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments
8:01am
8-K
EX-99.1
a0a10tt
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
424B5
fwdq111yvxr3h2f2est
1 Dec 22
Prospectus supplement for primary offering
4:05pm